结直肠癌
- 造模剂
- Dextran sulfate sodium
- 获批药物
- Bevacizumab
- Irinotecan hydrochloride
- Capecitabine
- Cetuximab
- Ramucirumab
- Oxaliplatin
- 5-FU
- Fruquintinib
- Ipilimumab
- Pembrolizumab
- Calcium folinate
- Trifluridine
- Tipiracil hydrochloride
- Nivolumab
- Panitumumab
- Regorafenib
- Tucatinib
- 化疗方案
-
- CAPOX
- Capecitabine
- Oxaliplatin
-
- FOLFIRI-BEVACIZUMAB
- Calcium folinate
- 5-FU
- Irinotecan hydrochloride
- Bevacizumab
-
- FOLFIRI-CETUXIMAB
- Calcium folinate
- 5-FU
- Irinotecan hydrochloride
- Cetuximab
-
- FOLFOX
- Calcium folinate
- 5-FU
- Oxaliplatin
-
- FU-LV
- 5-FU
- Calcium folinate
-
- XELOX
- Capecitabine
- Oxaliplatin
-
- FOLFIRINOX
- Calcium folinate
- 5-FU
- Irinotecan hydrochloride
- Oxaliplatin
- NCCN指南推荐 [1]
- 免疫检查点抑制剂
- 抗血管生成
- 靶向疗法 (A) [2]
-
- VEGF-A
- Bevacizumab
-
- Tubulin
- Paclitaxel
- Verubulin hydrochloride
- ABT-751
-
- CEACAM5
- Labetuzumab
- Labetuzumab govitecan
- 靶向疗法 (B) [2]
-
- HER2
- Trastuzumab
- Tucatinib
- TAS0728
-
- BRAF
- Encorafenib
-
- KRAS G12D
- MRTX1133
-
- VEGFR2
- Semaxanib
- Apatinib
- Ramucirumab
- 干细胞标志物 [3]
-
- Lgr5
- Petosemtamab
-
- CD44
- Bivatuzumab
- Angstrom6
-
- CD26
- Begelomab
-
- ALDH1
- Disulfiram
- NCT-501
- CM10
- 相关化合物库
- FDA-approved Anticancer Drug Library
- Anti-cancer Compound Library
- Anti-cancer Compound Library-Ⅱ
- Anti-cancer Metabolism Compound Library
- Cambridge Cancer Compound Library
- Small Molecule Immuno-Oncology Compound Library
- Tyrosine Kinase Inhibitor Library
- Angiogenesis Related compound Library
